Medicare Enrolled

Dr. Brian Kirschner, MD

Neurology · Farmington Hills, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
32255 NORTHWESTERN HWY STE 40, Farmington Hills, MI 48334
2483553875
In practice since 2006 (20 years)
NPI: 1205872058 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kirschner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kirschner? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kirschner

Dr. Brian Kirschner is a neurology specialist in Farmington Hills, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kirschner performed 419 Medicare services across 364 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kirschner received a total of $15,902 from 62 pharmaceutical and/or device companies across 649 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kirschner is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 34% volume in MI $15,902 industry payments

Medicare Practice Summary

Medicare Utilization ↗
419
Medicare services
Top 34% in MI for neurology
364
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~21 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
90 $89 $175
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
78 $59 $125
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
51 $125 $250
New patient office visit, complex (60-74 min) 49 $146 $365
Limited needle EMG of arm or leg muscles
A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area.
41 $49 $150
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
37 $138 $225
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
20 $85 $150
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
19 $78 $200
Nerve conduction study, 3-4 tests
A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function.
18 $89 $250
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
16 $131 $400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,902
Total received (2018-2024)
Avg $2,272/year across 7 years
Top 18% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
649
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,036 (69.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,839 (17.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,027 (12.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,612
2023
$1,718
2022
$2,252
2021
$3,498
2020
$787
2019
$3,995
2018
$2,041

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$333
ABBVIE INC.
$327
Neurocrine Biosciences, Inc.
$234
PFIZER INC.
$168
Celgene Corporation
$95
Novartis Pharmaceuticals Corporation
$86
Amneal Pharmaceuticals LLC
$48
Ipsen Biopharmaceuticals, Inc
$39
Biogen, Inc.
$39
Genentech USA, Inc.
$38
ACADIA Pharmaceuticals Inc
$37
Medtronic, Inc.
$34
UCB, Inc.
$27
Vanda Pharmaceuticals Inc.
$23
Eisai Inc.
$22
Azurity Pharmaceuticals, Inc.
$22
Abbott Laboratories
$21
Lilly USA, LLC
$18
Top 3 companies account for 55.5% of 2024 payments
All-time payments by company (2018-2024) ›
Amneal Pharmaceuticals LLC
$2,115
Novartis Pharmaceuticals Corporation
$1,362
Teva Pharmaceuticals USA, Inc.
$1,270
Janssen Scientific Affairs, LLC
$1,020
BANNER LIFE SCIENCES, LLC
$900
Biogen, Inc.
$857
EMD Serono, Inc.
$766
Neurocrine Biosciences, Inc.
$739
ABBVIE INC.
$683
Genentech USA, Inc.
$510
Amgen Inc.
$414
ACADIA Pharmaceuticals Inc
$395
GENZYME CORPORATION
$309
Celgene Corporation
$300
US WorldMeds, LLC
$294
Lilly USA, LLC
$283
PFIZER INC.
$280
Janssen Pharmaceuticals, Inc
$242
Allergan Inc.
$221
UCB, Inc.
$220
Saol Therapeutics Inc.
$201
Medtronic, Inc.
$185
Allergan, Inc.
$159
AbbVie, Inc.
$153
Ipsen Biopharmaceuticals, Inc
$149
Medtronic USA, Inc.
$145
Abbott Laboratories
$142
E.R. Squibb & Sons, L.L.C.
$124
TG THERAPEUTICS, INC.
$122
Impax Laboratories, Inc.
$110
Acorda Therapeutics, Inc
$109
BOSTON SCIENTIFIC CORPORATION
$73
Boston Scientific Corporation
$61
Bausch Health US, LLC
$61
Eisai Inc.
$59
Avanir Pharmaceuticals, Inc.
$56
GE HEALTHCARE
$54
Piramal Critical Care
$53
ARBOR PHARMACEUTICALS, INC.
$51
Lundbeck LLC
$51
AbbVie Inc.
$45
Sunovion Pharmaceuticals Inc.
$44
Merz Pharmaceuticals, LLC
$42
Alnylam Pharmaceuticals Inc.
$41
Supernus Pharmaceuticals, Inc.
$38
Upsher-Smith Laboratories LLC
$36
MDD US Operations, LLC
$36
Grifols USA, LLC
$34
Alexion Pharmaceuticals, Inc.
$32
GE HealthCare
$29
Genentech, Inc.
$23
Vanda Pharmaceuticals Inc.
$23
Azurity Pharmaceuticals, Inc.
$22
Biohaven Pharmaceutical Holding Company Ltd.
$22
PIRAMAL CRITICAL CARE
$20
Adamas Pharmaceuticals, Inc.
$19
Cala Health, Inc.
$19
Neurelis, Inc.
$18
OWP Pharmaceuticals, Inc.
$18
Merz North America, Inc.
$18
UPSHER-SMITH LABORATORIES LLC
$14
Egalet US Inc
$11
Top 3 companies account for 29.9% of all-time payments
Associated products mentioned in payments ›
ACTIVA · ACTIVA PC · ADUHELM · AIMOVIG · AJOVY · AMPLATZER Occluders · AMPYRA · AMYVID · APOKYN · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · CALA TRIO · COMIRNATY · CREXONT · DUOPA · DYSPORT · Duopa · Dysport · EMGALITY · Enspryng · GABLOFEN · GENERAL DBS · GENERAL DBS · GILENYA · GOCOVRI · Gamunex-C · General - DBS · HORIZANT · Horizant · INBRIJA · INFINITY · INGREZZA · INVOKANA · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LUMIZYME · Lamotrigine Starter Kit · Leqembi · Lioresal (baclofen) · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NUPLAZID · NURTEC ODT · Nuedexta · OCREVUS · ONPATTRO · Ocrevus · Ocrevus Zunovo · Ongentys · PONVORY · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Ponvory · Prolia · QULIPTA · RYTARY · Rebif · Rystiggo · SOLIRIS · SPRIX · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRUMENBA · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VYALEV · VYEPTI · Vimpat · XEOMIN · Xadago · Xeomin · ZAVZPRET · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (69%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Farmington Hills?
Compare neurologists in the Farmington Hills area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
356
Per 100K population
28.0
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL - FARMINGTON HILLS
2.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kirschner is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 18% of MI peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kirschner experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kirschner performed 90 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kirschner receive payments from pharmaceutical companies?
Yes. Dr. Kirschner received a total of $15,902 from 62 companies across 649 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kirschner's costs compare to other neurologists in Farmington Hills?
Dr. Kirschner's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kirschner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →